Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network.
Pauline GandolfoThomas SoeiroÉlisabeth JouveBruno RevolAmélie DaveluyCélian BertinCéline EidenValérie GibajaLeila ChaouachiMarie-Christine Pérault-PochatCécile ChevallierAurélie AquizérateReynald Le BoisselierLouise CartonMaryse Lapeyre MestreElisabeth FraugerClémence LacroixJoëlle MicallefPublished in: Fundamental & clinical pharmacology (2024)
The trend observed over 10 years reflects the growth in ketamine use among people with substance use disorder, although it does not allow to estimate the rates of non-medical use of ketamine in the general population. Ketamine-induced uropathy and cholangiopathy are reported in ketamine users with substance use disorder, especially in case of repeated and/or prolonged use of high doses.